Here's how NCBI.NLM.NIH.GOV makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NCBI . NLM . NIH . GOV {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Ncbi.nlm.nih.gov Make Money
  6. Keywords
  7. Topics
  8. Social Networks
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. Hosting Providers
  13. CDN Services

We began analyzing https://pmc.ncbi.nlm.nih.gov/articles/PMC11029415/, but it redirected us to https://pmc.ncbi.nlm.nih.gov/articles/PMC11029415/. The analysis below is for the second page.

Title[redir]:
CAR T cells targeting solid tumors: carcinoembryonic antigen (CEA) proves to be a safe target - PMC
Description:
No description found...

Matching Content Categories {📚}

  • Insurance
  • Science
  • Luxury

Content Management System {📝}

What CMS is ncbi.nlm.nih.gov built with?

Custom-built

No common CMS systems were detected on Ncbi.nlm.nih.gov, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of ncbi.nlm.nih.gov audience?

🚀🌠 Tremendous Traffic: 10M - 20M visitors per month


Based on our best estimate, this website will receive around 11,707,788 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Ncbi.nlm.nih.gov Make Money? {💸}

We're unsure how the site profits.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Ncbi.nlm.nih.gov might have a hidden revenue stream, but it's not something we can detect.

Keywords {🔍}

car, cells, cell, cea, cancer, patients, pmc, nct, doi, nlm, targeting, antigen, anticea, ncbi, search, article, transient, infusion, scfv, days, serum, trial, carcinoembryonic, clinical, efficacy, toxicity, trials, treatment, systemic, administration, therapy, cohort, dose, doses, severe, activation, respiratory, engineered, metastatic, metastases, preconditioning, flu, total, healthy, luminal, tcr, free, pubmed, google, scholar,

Topics {✒️}

bw431/26 scfv-igg4 hinge-cd28–cd3ζ mn14 scfv-cd8hinge-cd28–cd3ζ optimal pre-conditioning regimen chimeric antigen receptor inducing auto-immune toxicity pmc beta search distal n-a1 domain generation cd28–cd3ζ car cd28–cd3ζ car trial membrane-proximal cea epitope cancer immunol immunother γ-retrovirus patient cohorts productive anti-tumor response publisher site pdf recent anti-cea car distal epitope independently mfe23 scfv-cd3ζ ethical standards conflict serum ifn-γ median age 58 years median age 48 years metastatic colorectal cancer license information pmcid metastatic colorectal cancers inducing lasting remissions clin cancer res cancer cell membrane systemic il-2 support generation cd3ζ car anti-tumor responses cd3ζ car trial generation carcinoembryonic antigen united states government decreased tumor progression requiring artificial respiration monitor tumor load respiratory toxicity hepatic artery infusion lung capillaries immediately adoptive therapy trials high il-2 doses therapy targeting cea extracellular cea moiety cea levels declined car molecules required lesion remains small clinically relevant inflammation side effects versus severe adverse events entire cell surface

External Links {🔗}(24)

Analytics and Tracking {📊}

  • Google Analytics
  • Google Analytics 4
  • Google Tag Manager

Libraries {📚}

  • jQuery
  • jQuery module (jquery-3.6.0)

Emails and Hosting {✉️}

Mail Servers:

  • nihcesxway.hub.nih.gov
  • nihcesxway2.hub.nih.gov
  • nihcesxway3.hub.nih.gov
  • nihcesxway4.hub.nih.gov
  • nihcesxway5.hub.nih.gov

Name Servers:

  • dns1-ncbi.ncbi.nlm.nih.gov
  • dns2-ncbi.ncbi.nlm.nih.gov
  • lhcns1.nlm.nih.gov
  • lhcns2.nlm.nih.gov

CDN Services {📦}

  • Ncbi

2.77s.